| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.76B | +35.4% |
| Cost of Revenue | $3.39B | +34.5% |
| Gross Profit | $368.0M | +44.9% |
| R&D Expense | $196.0M | +2.6% |
| SG&A Expense | $188.0M | +7.4% |
| Interest Expense | $14.0M | +40.0% |
| Pre-tax Income | $175.0M | +116.0% |
| Income Tax | $45.0M | +45.2% |
| Net Income | $124.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $520.0M | +15.0% |
| Accounts Receivable | $672.0M | +22.4% |
| Inventory | $348.0M | +32.8% |
| Current Assets | $1.71B | +20.1% |
| Total Assets | $2.45B | +9.7% |
| Current Liabilities | $1.03B | +21.5% |
| Long-term Debt | $336.0M | -3.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $167.0M | +187.9% |
| Investing Cash Flow | -$68.0M | -7.9% |
| Financing Cash Flow | -$9.0M | +69.0% |
| +202.4% |
| EPS (Basic) | $4.41 | +202.1% |
| EPS (Diluted) | $4.35 | +202.1% |
| Stockholders' Equity |
| $675.0M |
| +30.8% |